{
    "root": "d752e6b5-5f7d-4a9e-bde2-cd468e01c22a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "OMNISCAN",
    "value": "20250311",
    "ingredients": [
        {
            "name": "CALDIAMIDE SODIUM",
            "code": "1M6415C70M"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "GADODIAMIDE",
            "code": "84F6U3J2R6",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37333"
        }
    ],
    "indications": {
        "text": "omniscan gadolinium-based contrast agent diagnostic magnetic resonance imaging ( mri ) indicated intravenous : visualize lesions abnormal vascularity brain , spine , associated tissues ( 1.1 ) facilitate visualization lesions abnormal vascularity within thoracic , abdominal , pelvic cavities , retroperitoneal space ( 1.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "cns \u2013 adults pediatrics ; 2 16 years age : 0.2 ml/kg ( 0.1 mmol/kg ) ( 2.1 , 2.4 ) body \u2013 adults pediatrics ; 2 16 years age : kidney : 0.1 ml/kg ( 0.05 mmol/kg ) intrathoracic , intra-abdominal , pelvic cavities : 0.2 ml/kg ( 0.1 mmol/kg ) ( 2.2 , 2.4 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "omniscan ( gadodiamide ) injection sterile , clear , colorless slightly yellow , aqueous solution containing 287 mg/ml gadodiamide rubber stoppered vials . omniscan supplied following sizes : 10 ml vial , box 10 ( ndc 0407-0690-10 ) 15 ml fill 20 ml vial , box 10 ( ndc 0407-0690-15 ) 20 ml vial , box 10 ( ndc 0407-0690-20 )",
    "adverseReactions": "omniscan contraindicated patients : chronic , severe kidney disease ( glomerular filtration rate , gfr < 30 ml/min/1.73m2 ) acute kidney injury prior hypersensitivity omniscan",
    "indications_original": "OMNISCAN is a gadolinium-based contrast agent for diagnostic magnetic resonance imaging (MRI) indicated for intravenous use to: Visualize lesions with abnormal vascularity in the brain, spine, and associated tissues ( 1.1 ) Facilitate the visualization of lesions with abnormal vascularity within the thoracic, abdominal, pelvic cavities, and the retroperitoneal space ( 1.2 )",
    "contraindications_original": "CNS \u2013 Adults and Pediatrics; 2 to 16 years of age: 0.2 mL/kg (0.1 mmol/kg) ( 2.1 , 2.4 ) Body \u2013 Adults and Pediatrics; 2 to 16 years of age: Kidney: 0.1 mL/kg (0.05 mmol/kg) Intrathoracic, intra-abdominal, and pelvic cavities: 0.2 mL/kg (0.1 mmol/kg) ( 2.2 , 2.4 )",
    "warningsAndPrecautions_original": "OMNISCAN (gadodiamide) Injection is a sterile, clear, colorless to slightly yellow, aqueous solution containing 287 mg/mL of gadodiamide in rubber stoppered vials. OMNISCAN is supplied in the following sizes:\n                  10 mL vial, box of 10 (NDC 0407-0690-10) 15 mL fill in 20 mL vial, box of 10 (NDC 0407-0690-15) 20 mL vial, box of 10 (NDC 0407-0690-20)",
    "adverseReactions_original": "OMNISCAN is contraindicated in patients with:\n                  \n                     Chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m2) or acute kidney injury  \n                     Prior hypersensitivity to OMNISCAN",
    "drug": [
        {
            "name": "OMNISCAN"
        }
    ]
}